Researchers have discovered two genes, RNF144B and ENPP1, that cause calcium pyrophosphate deposition (CPPD) disease in Americans of European and African descent. This crystalline arthritis is ...

This data represented the first-ever research presented at ACR on both fractures and calcium pyrophosphate deposition disease.

Calcium pyrophosphate deposition (CPDD) disease is characterized by the accumulation of calcium crystals in the cartilage tissues of the joints. The crystal deposits cause inflammation of the ...

A study in the Annals of the Rheumatic Diseases uncovers new genetic links to calcium pyrophosphate deposition (CPPD) disease, a common type of inflammatory arthritis. This image shows an X-ray ...

They report a doubled risk of fractures in patients with acute calcium pyrophosphate crystal arthritis compared to those without the disease (Abstract #0235).

This crystalline arthritis is caused by calcium pyrophosphate (CPP) crystal deposition in joints.

Patients with calcium pyrophosphate deposition (CPPD) disease, also known as pseudogout, have an 80% higher risk for fracture than individuals who do not have the disease, according to a new ...

Calcium pyrophosphate disease remains—50 years after its initial description—a challenging disease to diagnose and manage. Newly-reached consensus among European experts suggests standard ...

Machine learning models diagnosed gout and calcium pyrophosphate deposition with accuracies similar to trained observers. The models could be applied at point of care without specific training.

A groundbreaking study in the Annals of the Rheumatic Diseases uncovers new genetic links to calcium pyrophosphate deposition (CPPD) disease, a common type of inflammatory arthritis.